Kiener Peter A
SEC CIK 1328146 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CUE | Cue Biopharma, Inc. | Dir | 9,682 | — | $392.3K | 4 | 2021-11-15 | 2023-03-23 |
Most active insiders at CUE, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Lin Shao-Lee | CEO, Dir | — | $1.61M |
| 2 | Ray Sumita | Chief Legal Compliance Off, Corp. Sec | — | $265.6K |
| 3 | Meluzio Michael Vincent | VP, Prin. Accounting Off | — | $169.3K |
| 4 | Sarraf Pasha | Dir | $99.7K | — |
| 5 | Meehan Viola Mong | Dir | — | — |
| 6 | Borie Dominique Christian | Chief Medical Off, Head of Research, Development | — | — |
| 7 | Garzone Pamela | Dir | — | — |
| 8 | Camardo Daniel A. | Dir | — | — |
| 9 | Ahlers James M | CFO | — | — |
Kiener Peter A made no open-market trades at CUE in the last 12 months.
Transactions 4
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-03-27 | 2023-03-23 | CUE | Cue Biopharma, Inc. | Kiener Peter A | Dir | M - OptEx | $2.86 | +9,682 | 9,682 | New | +$27.7K |
| D | 2023-03-27 | 2023-03-23 | CUE | Cue Biopharma, Inc. | Kiener Peter A | Dir | S - Sale+OE | $3.28 | -9,325 | 357 | -96% | -$30.6K |
| DM | 2021-11-17 | 2021-11-15+ | CUE | Cue Biopharma, Inc. | Kiener Peter A | Dir | M - OptEx | $2.86 | +20.2K | 1,361 | New | +$57.7K |
| DM | 2021-11-17 | 2021-11-15+ | CUE | Cue Biopharma, Inc. | Kiener Peter A | Dir | S - Sale+OE | $17.93 | -20.2K | 0 | -100% | -$361.7K |
Purchase Sale Sale after option exercise All abbreviations